An online survey of the attitude and willingness of Chinese adults to receive COVID-19 vaccination (original) (raw)
Related papers
Acceptance, Concerns and Knowledge of COVID-19 Vaccine: An Early Battle Against the Pandemic
JOURNAL OF SUSTAINABILITY SCIENCE AND MANAGEMENT
Many COVID-19 vaccine candidates were clinically tested in response to the coronavirus pandemic. This study aims to determine the acceptance rate of, main concerns about and knowledge of COVID-19 vaccination among the Malaysian population based on different sociodemographic characteristics during the early stages of vaccine arrival in Malaysia. A cross-sectional online survey was performed between January 25, 2021 and February 1, 2021 using descriptive statistics, Likert scale analysis, hypothesis testing, correlation and regression. These statistics assessed the correlation between sociodemographic characteristics, exposure to COVID-19 vaccine information, as well as the perceived risk of infection and acceptance towards COVID-19 vaccines. There exist significant differences across sociodemographic variables. More than half of the respondents (58.85%) voted safety as their primary concern. Moreover, a medium correlation exists between knowledge and acceptance, r = 0.444, N = 2051, ...
Knowledge, Attitude and Acceptance of a COVID-19 Vaccine: A Global Cross-Sectional Study
International Research Journal of Business and Social Science, 2020
The COVID-19 pandemic continues to ravage the world, with the United States being highly affected. A vaccine provides the best hope for a permanent solution to controlling the pandemic. Several coronavirus disease (COVID-19) vaccines are currently in human trials. However, to be effective, a vaccine must be accepted and used by a large majority of the population. This study aimed to investigate the acceptability of COVID-19 vaccines and its predictors in addition to the attitudes towards these vaccines among public. This study did an online survey during the period June-September 2020, were collected from 26,852 individuals aged 19 years or older across six continents as part of 60 nationally representative surveys to determine potential acceptance rates and factors influencing acceptance of a COVID-19 vaccine. Results revealed that two-thirds of respondents were at least moderately worried about a widespread COVID-19 outbreak. Differences in acceptance rates ranged from almost 93% (in Tonga) to less than 43% (in Egypt). Respondents reporting higher levels of trust in information from government sources were more likely to accept a vaccine and take their employer's advice to do so. Systematic interventions are required by public health authorities to reduce the levels of vaccines' hesitancy and improve their acceptance. These results and specifically the low rate of acceptability is alarming to public health authorities and should stir further studies on the root causes and the need of awareness campaigns. These interventions should take the form of reviving the trust in national health authorities and structured awareness campaigns that offer transparent information about the safety and efficacy of the vaccines and the technology that was utilized in their production.
2021
Why vaccinations? Vaccines help people survive. Vaccines save 5 lives every minute. The eradication of smallpox-a serious disease that left even survivors scarred for life-alone saves an estimated 5 million lives every year. If a vaccine had not eradicated smallpox, someone would now die from the disease every 6 seconds of every day. Prior to the introduction of a vaccine, as recently as 1980, measles caused more than 2.6 million deaths globally. SUCCESS OF VACCINES Vaccines can only save lives if people are vaccinated. Fortunately, most people get vaccinated. For example, 85% of children worldwide are vaccinated against diphtheria, tetanus, and pertussis (whooping cough), and in 125 countries that figure exceeds 90%. Why COVID-19 vaccinations? COVID-19 is a serious disease. In only 10 months the SARS-CoV-2 virus infected over 78 million people across the world, killing 1.7 million 1. COVID-19 patients require intensive care in hospital at a rate more than 6 times greater than during the influenza pandemic in 2009 2. Many survivors are faced with sometimes severe long-term health impacts 3,4. COVID-19 is not like the flu. It is more contagious, more deadly, and is spreading across a world where no-one was immune. 2 FACTS ABOUT COVID-19 While behavioral measures such as isolating while symptomatic, mask-wearing and physical distancing have slowed the spread of the virus, vaccines provide a better path out of the COVID-19 pandemic, and scientists have now developed several highly effective vaccines against COVID-19. BEHAVIORS TO CONTROL COVID-19 DETERMINANTS OF COVID-19 VACCINE UPTAKE What variables increase hesitancy about COVID-19 vaccines? Research has also considered the flipside, by examining the factors that may lead to hesitancy towards the COVID-19 vaccine. • Some people oppose the vaccine for ideological reasons because COVID-19 and the response to it have become politicized in some countries. When this occurs, opposition is generally greater on the political right and among populists 15,16. POLITICS OF COVID-19 VACCINATION • About a third of people who are not intending to be vaccinated against COVID-19 are committed vaccination opponents 16 and often believe in conspiracy theories. VACCINE DENIERS CONSPIRACY THEORIES • Some people understand the need for a COVID-19 vaccine but have safety concerns. FACTS ABOUT COVID-19 VACCINES COVID-19 VACCINE DEVELOPMENT PROCESS • People of color, immigrants, LGBTQ individuals, homeless or low-income people, people with disabilities and other marginalized populations traditionally face obstacles and inequalities in healthcare and this situation has been exacerbated by the COVID-19 pandemic. They may also have collective histories of experience with medical malpractice that affect current trust.
Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre-including this research content-immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
Journal of Education and Health Promotion, 2021
BACKGROUND: Coronavirus disease rapidly spreads across the entire world in < 2 months and gravely jeopardizes the regular human routine. The medical fraternity recommends a vaccine as one of the best solutions to save the universe. However, to be effective, the population should reflect an encouraging attitude to accept it. The study aimed to measure vaccine acceptability and reason for hesitancy among the public. MATERIALS AND METHODS: Eight hundred and forty one adults visiting a tertiary care hospital responded to a pretested validated questionnaire on vaccine acceptability and hesitancy. The Chi-square test and independent t-test, followed by multinomial logistic regression, were used to analyze the findings. RESULTS: Overall, 53.4% (n = 445) of participants interested to take vaccine, 27.2% (n = 229) were not sure, and the remaining 19.4% (n = 163) did not intent to vaccinate. Gender (P = 0.013), information on the vaccine (P = 0.022), chances to get coronavirus disease in t...
A global survey of potential acceptance of a COVID-19 vaccine
Nature Medicine
Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June 2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates and factors influencing acceptance of a COVID-19 vaccine. Of these, 71.5% of participants reported that they would be very or somewhat likely to take a COVID-19 vaccine, and 48.1% reported that they would accept their employer's recommendation to do so. Differences in acceptance rates ranged from almost 90% (in China) to less than 55% (in Russia). Respondents reporting higher levels of trust in information from government sources were more likely to accept a vaccine and take their employer's advice to do so. The COVID-19 pandemic is expected to continue to impose enormous burdens of morbidity and mortality while severely disrupting societies and economies worldwide. Governments must be ready to ensure large-scale, equitable access and distribution of a COVID-19 vaccine if and when a safe and effective one becomes available. This will require sufficient health system capacity, as well as strategies to enhance trust in and acceptance of the vaccine and those who deliver it. In 2015, the World Health Organization (WHO) Strategic Advisory Group of Experts on Immunization defined vaccine hesitancy as a ' delay in acceptance or refusal of vaccination despite availability of vaccination services' 1 , which can vary in form and intensity based on when and where it occurs and what vaccine is involved, as has been confirmed in multiple studies 2,3. Concern about vaccine hesitancy is growing worldwide 4 ; in fact, WHO identified it as one of the top ten global health threats in 2019 (https://www.who. int/news-room/spotlight/ ten-threats-to-global-health-in-2019). In many countries, vaccine hesitancy and misinformation present substantial obstacles to achieving coverage and community immunity 5,6. Governments, public health officials and advocacy groups must be prepared to address hesitancy and build vaccine literacy so that the public will accept immunization when appropriate. Anti-vaccination activists are already campaigning in multiple countries against the need for a vaccine, with some denying the existence of COVID-19 altogether 7. Misinformation spread through multiple channels could have a considerable effect on the acceptance of a COVID-19 vaccine 8. The accelerated pace of vaccine development has further heightened public anxieties and could compromise acceptance 9. Governments and societies must gauge current levels of willingness to receive a potentially safe and effective COVID-19 vaccine and identify correlates of vaccine hesitancy and/or acceptance. We present findings from a survey of the likelihood of vaccine acceptance from a sample of 13,426 respondents in 19 countries.
Knowledge, beliefs, and acceptability of people toward new COVID-19 vaccines: a pilot study
Human Vaccines & Immunotherapeutics, 2021
A cross-section pilot study was done to determine the knowledge and belief toward new COVID-19 vaccines among a small sample size group of people. A new Vaccine Acceptability Questionnaire (VAQ) consists of 31 questions that were concerned about three elements: underlying factors, knowledge, and beliefs. The study included 96 people from the different regions of Saudi Arabia who had accepted to participate in this pilot study. Around 31% of the included people had low to very low acceptability toward COVID-19 vaccines; however, the other 69% had moderate to high acceptability. The new simple designed questionnaire (VAQ) could be effective in assessing knowledge, beliefs, and acceptability toward COVID-19 vaccination among a specific group of population.
Knowledge, attitudes and perceptions of a patient population on the COVID-19 vaccine rollout
Health Sa Gesondheid, 2022
Background: The coronavirus disease 2019 (COVID-19) pandemic has had dire effects on South Africa. Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are critical in the fight against COVID-19. This study is necessary to optimise vaccine acceptance. Aim: To determine the knowledge, attitudes and perceptions of a patient population in South Africa on the COVID-19 vaccine rollout. Setting: This study was conducted via a retail pharmacy in Merebank, Wentworth and Bluff (Ward 68), which is in the eThekwini Metropolitan Municipality in the KwaZulu-Natal province. Methods: A quantitative study was conducted using an online self-administered questionnaire between April 2021 to September 2021. There were a total of 430 participants. Data were collected on Google Forms, recorded in Microsoft Excel and analysed using descriptive and inferential statistics. Results: Knowledge of COVID-19 in the population was 81.86%. A total of 65% of participants stated that they would definitely take the COVID-19 vaccine, and 33.7% stated that they were hesitant to receive the vaccine. Reasons for hesitancies included concerns surrounding side effects of the vaccines, its safety and efficacy and the fast-tracking of the vaccine. Conclusion: Education campaigns need to be customised to provide the population with reliable and vetted vaccine information and address specific concerns or hesitancies present. Health care workers and the government need to work with religious leaders to improve public trust and confidence in the vaccine. To reach herd immunity and prevent increased morbidity rates, there needs to be a rise in vaccine acceptance across South Africa and globally. Contribution: With the intention of ensuring a successful COVID-19 vaccine rollout strategy in South Africa, it is of great importance to address the reasons for vaccine hesitancy and to determine the knowledge, attitudes and perceptions of the population on the COVID-19 vaccines. This study will therefore aid in developing strategies aimed at improving vaccine education and awareness, thereby resulting in a greater uptake of the COVID-19 vaccine by the population.
Advances in Health Sciences Research
Background: Developing a vaccine against COVID-19 is widely regarded as a critical method for containing the pandemic. Public adoption, on the other hand, is contingent on one's view's to accept and perceptions about the vaccine. The aim of this literature review is to determine the factors that influence public acceptance and hesitancy against Covid-19 vaccines. Objective: To determine the sociodemographic features associated with the public's understanding and acceptance or fear of Covid-19 vaccines. To ascertain the causes that contribute to acceptance or refusal of the Covid vaccine. Method: 22 articles were searched and selected through PubMed database, Google Scholar database, and Scopus database between January 1st, 2020 to 30th December 2020. Discussion: The finding indicates that the United States and the United Kingdom have done the most research on the adoption and rejection of the Covid-19 vaccine, whereas China's experiments have the largest citation rate. The literature indicates that the Australian community has the highest acceptance rate, whereas the Netherlands has the highest distrust and hesitancy toward the Covid-19 vaccine. Conclusion: The Covid-19 virus is urged to be given to the population's needs toward the vaccine but at the same time acceptance rate was varied between each countries population and fear of conspiracy ideas from some countries. Some countries are concerned about the safety of the vaccine being given to their citizens.
The Lancet, 2021
Since the first case of COVID-19 was identified in the USA in January, 2020, over 46 million people in the country have tested positive for SARS-CoV-2 infection. Several COVID-19 vaccines have received emergency use authorisations from the US Food and Drug Administration, with the Pfizer-BioNTech vaccine receiving full approval on Aug 23, 2021. When paired with masking, physical distancing, and ventilation, COVID-19 vaccines are the best intervention to sustainably control the pandemic. However, surveys have consistently found that a sizeable minority of US residents do not plan to get a COVID-19 vaccine. The most severe consequence of an inadequate uptake of COVID-19 vaccines has been sustained community transmission (including of the delta [B.1.617.2] variant, a surge of which began in July, 2021). Exacerbating the direct impact of the virus, a low uptake of COVID-19 vaccines will prolong the social and economic repercussions of the pandemic on families and communities, especially lowincome and minority ethnic groups, into 2022, or even longer. The scale and challenges of the COVID-19 vaccination campaign are unprecedented. Therefore, through a series of recommendations, we present a coordinated, evidencebased education, communication, and behavioural intervention strategy that is likely to improve the success of COVID-19 vaccine programmes across the USA.